SCHEMBL6313419

SCHEMBL6313419

Brc1csc(C#Cc2ccccc2)n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 14/20 0.66
APP P05067 1/20 0.46
CHEK1 O14757 1/20 0.41
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
CYP2C19 P33261 1/20 0.38
THPO P40225 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
GRIN2B Q13224 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7387992 0.95 GRM5 (0.60) GRM5APPCHEK1
SCHEMBL1656957 0.79 GRM5 (0.58) GRM5CHEK1KDM4E
SCHEMBL15692608 0.76 GRM5 (0.55) GRM5APPCHEK1NPC1ALDH1A1
SCHEMBL1656880 0.73 TDP1 (0.59) GRM5CHEK1KDM4EMEN1NPC1
SCHEMBL24075982 0.72 GRM5 (0.54) GRM5APPCHEK1KDM4EMEN1
SCHEMBL1657308 0.71 GRM5 (0.52) GRM5CHEK1NPC1ALOX15RAB9A
SCHEMBL21189528 0.69 GRM5 (0.33) GRM5
SCHEMBL15322434 0.69
Diphenylacetylene SCHEMBL29188592 0.68 APP (1.00) GRM5APPKDM4EMEN1NPC1
Diphenylacetylene SCHEMBL960609 0.68 APP (1.00) GRM5APPKDM4EMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014065411-A1 SULFONAMIDE DERIVATIVE AS HARMFUL-ORGANISM CONTROL AGENT FOR AGRICULTURAL/HORTICULTURAL USE 株式会社エス・ディー・エス バイオテック (JP) 2014-05-01 WO disclosed
US-6956049-B1 Methods of modulating processes mediated by excitatory amino acid receptors MERCK & CO., INC. (US) 2005-10-18 US disclosed
EP-1214303-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF Merck & Co., Inc. (US) 2002-06-19 EP disclosed
WO-2001016121-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF MERCK & CO., INC. (US) 2001-03-08 WO disclosed